Engrail Therapeutics


Transforming the lives of patients with life-limiting diseases of the nervous system. Acquiring, developing and commercializing transformative medicines.

Employees

11-50

Links


Org chart

Vikram Sudarsan
President, CEO & Board Member
Collapse
Rex E. Bosen
Acting CFO
Stephen Cunningham
Chief Development Officer & Board Member
Eve M. Taylor, PhD
Executive Vice President, Clinical Program Management And Regulatory Affairs
Paul Cayer
Chief Financial Officer
Quentin McCubbin
Chief Technical Officer
Kimberly Vanover
Chief Scientific Officer
Lisa Toward
Office Manager - Executive Assistant
Lisa Toward
Office Manager & Executive Assistant
Camilla Gomiero
VP, Commercial Strategy

Board & advisors

Karoly Nikolich
Board Member
Tony Ho
Board Member


Offices